Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation With a Conditioning Regimen of Targeted Busulfan, Cyclophosphamide, and Thymoglobulin.

Trial Profile

Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation With a Conditioning Regimen of Targeted Busulfan, Cyclophosphamide, and Thymoglobulin.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Feb 2011

At a glance

  • Drugs Antithymocyte globulin (Primary) ; Busulfan (Primary) ; Cyclophosphamide (Primary)
  • Indications Graft-versus-host disease; Haematological malignancies
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Feb 2011 Planned end date changed from 1 Dec 2008 to 1 Sep 2008 as reported by ClinicalTrials.gov.
    • 04 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Feb 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top